A Louisiana bill that died in the Senate would have prevented CVS from operating in the state as a pharmacy while also owning ...

CVS Health (NYSE:CVS) snapped seven straight sessions of gains as the stock closed 0.92% lower, at $67.09 on Tuesday. The ...

CVS Health plans to invest $20 billion in technology over the next 10 years to deliver a more consumer-centric health ...

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

CVS, BrightSpring, and GeneDx are tapping into AI, staffing trends, and precision medicine to drive future healthcare gains.

The eight-week regular session ended with lawmakers backing the less stringent of two measures aimed at regulating pharmacy ...

As Walgreens exits Wall Street after 98 years, its new owners face a daunting turnaround. Will a renewed focus on its ...

Ariel Investments, an investment management company, released its “Ariel Global Fund” first-quarter 2025 investor letter. A ...

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy.

Kristin Begley's career has revolved around making prescriptions more accessible and affordable for individuals and companies ...